NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2085392961|ref|WP_221679331|]
View 

NAD(P)H-dependent oxidoreductase [Enterococcus sp. K18_3]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
PubMed:  25372605|7568029
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
4-188 8.86e-46

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 149.22  E-value: 8.86e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   4 TLIID-HPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDGFDPVMKKEELavYQSGSvLDPLVLHYMSLLKVTTQLVLI 82
Cdd:COG2249     2 ILIIYaHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF--YRDGP-LPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961  83 FPIWWYSSPASLKGFLDKVLLNEFAFFDGGNGIQPLLSIDSVVVFTTSDQPTASLEQRCTRSY-KHQLT-MTLEDIGMRN 160
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPiEELLFrGTLGYCGMKV 158
                         170       180
                  ....*....|....*....|....*...
gi 2085392961 161 ISWYHLGAVKNTTEEERIEYLDSVYEKL 188
Cdd:COG2249   159 LPPFVLYGVDRSSDEERAAWLERVRELL 186
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
4-188 8.86e-46

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 149.22  E-value: 8.86e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   4 TLIID-HPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDGFDPVMKKEELavYQSGSvLDPLVLHYMSLLKVTTQLVLI 82
Cdd:COG2249     2 ILIIYaHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF--YRDGP-LPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961  83 FPIWWYSSPASLKGFLDKVLLNEFAFFDGGNGIQPLLSIDSVVVFTTSDQPTASLEQRCTRSY-KHQLT-MTLEDIGMRN 160
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPiEELLFrGTLGYCGMKV 158
                         170       180
                  ....*....|....*....|....*...
gi 2085392961 161 ISWYHLGAVKNTTEEERIEYLDSVYEKL 188
Cdd:COG2249   159 LPPFVLYGVDRSSDEERAAWLERVRELL 186
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-111 6.41e-21

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 85.52  E-value: 6.41e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   1 MTTTLIIDHPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDGFDPVMKKEELAVYQS-GSVLDPLVLHYMSLLKVTTQL 79
Cdd:PRK09739    4 MRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQVEELDLYRSGFDPVLTPEDEPDWKNpDKRYSPEVHQLYSELLEHDAL 83
                          90       100       110
                  ....*....|....*....|....*....|..
gi 2085392961  80 VLIFPIWWYSSPASLKGFLDKVLLNEFAFFDG 111
Cdd:PRK09739   84 VFVFPLWWYSFPAMLKGYIDRVWNNGLAYGDG 115
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 6.76e-20

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 82.38  E-value: 6.76e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   2 TTTLIID-HPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDgFDPVMKKEELAVYqSGSVLDPLVLHYMSLLKVTTQLV 80
Cdd:pfam02525   1 MKILIINaHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLADL-TYPQGAADVESEQEELLAADVIV 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961  81 LIFPIWWYSSPASLKGFLDKVLLNEFAF-FDGGNGIQPLLSIDSVVVFTTSDQPTASLEQRCT--RSYKHQLT---MTLE 154
Cdd:pfam02525  79 FQFPLYWFSVPALLKGWIDRVLRAGFAFkYEEGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYngFSLDELLPylrGILG 158
                         170       180       190
                  ....*....|....*....|....*....|....*
gi 2085392961 155 DIGMRNISWYHLGAVKNTTEEERI-EYLDSVYEKL 188
Cdd:pfam02525 159 FCGITDLPPFAVEGTAGPEDEAALaEALERYEERL 193
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
4-188 8.86e-46

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 149.22  E-value: 8.86e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   4 TLIID-HPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDGFDPVMKKEELavYQSGSvLDPLVLHYMSLLKVTTQLVLI 82
Cdd:COG2249     2 ILIIYaHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF--YRDGP-LPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961  83 FPIWWYSSPASLKGFLDKVLLNEFAFFDGGNGIQPLLSIDSVVVFTTSDQPTASLEQRCTRSY-KHQLT-MTLEDIGMRN 160
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPiEELLFrGTLGYCGMKV 158
                         170       180
                  ....*....|....*....|....*...
gi 2085392961 161 ISWYHLGAVKNTTEEERIEYLDSVYEKL 188
Cdd:COG2249   159 LPPFVLYGVDRSSDEERAAWLERVRELL 186
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-111 6.41e-21

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 85.52  E-value: 6.41e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   1 MTTTLIIDHPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDGFDPVMKKEELAVYQS-GSVLDPLVLHYMSLLKVTTQL 79
Cdd:PRK09739    4 MRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQVEELDLYRSGFDPVLTPEDEPDWKNpDKRYSPEVHQLYSELLEHDAL 83
                          90       100       110
                  ....*....|....*....|....*....|..
gi 2085392961  80 VLIFPIWWYSSPASLKGFLDKVLLNEFAFFDG 111
Cdd:PRK09739   84 VFVFPLWWYSFPAMLKGYIDRVWNNGLAYGDG 115
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 6.76e-20

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 82.38  E-value: 6.76e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961   2 TTTLIID-HPWKESFNHAVLNKLITGLEQDQKIYQVIDLNKDgFDPVMKKEELAVYqSGSVLDPLVLHYMSLLKVTTQLV 80
Cdd:pfam02525   1 MKILIINaHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLADL-TYPQGAADVESEQEELLAADVIV 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2085392961  81 LIFPIWWYSSPASLKGFLDKVLLNEFAF-FDGGNGIQPLLSIDSVVVFTTSDQPTASLEQRCT--RSYKHQLT---MTLE 154
Cdd:pfam02525  79 FQFPLYWFSVPALLKGWIDRVLRAGFAFkYEEGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYngFSLDELLPylrGILG 158
                         170       180       190
                  ....*....|....*....|....*....|....*
gi 2085392961 155 DIGMRNISWYHLGAVKNTTEEERI-EYLDSVYEKL 188
Cdd:pfam02525 159 FCGITDLPPFAVEGTAGPEDEAALaEALERYEERL 193
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
79-113 1.87e-03

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 37.29  E-value: 1.87e-03
                          10        20        30
                  ....*....|....*....|....*....|....*
gi 2085392961  79 LVLIFPIWWYSSPASLKGFLDKVLLNEFAFFDGGN 113
Cdd:PRK04930   65 IVFQHPLYTYSCPALLKEWLDRVLSRGFASGPGGN 99
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH